Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target

Journal of Infectious Diseases

Volumn 201, Issue 11, 2010, Pages 1718-1728

  Luo, Guanpingsheng ^a   Ibrahim, Ashraf S ^a,b   Spellberg, Brad ^a,b   Nobile, Clarissa J ^c   Mitchell, Aaron P ^d   Fu, Yue ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS VACCINE; RECOMBINANT HYR1P PROTEIN; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BCR1P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL KILLING; CONTROLLED STUDY; DRUG TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INVASIVE CANDIDIASIS; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; FUNGAL PROTEINS; FUNGAL VACCINES; LIVER; MICE; MICE, INBRED C57BL; MICROBIAL VIABILITY; NEUTROPHILS; SPLEEN; SURVIVAL ANALYSIS; VIRULENCE FACTORS;

EID: 77951893909     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652407     Document Type: Article

References (27)

1. Spellberg BJ, Filler SG, Edwards JE Jr. Current treatment strategies for disseminated candidiasis. Clin Infect Dis 2006;42:244-251. (Pubitemid 43054198)
2. Del Poeta M. Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot Cell 2004;3:1067-1075.
3. Koh AY, Kohler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog 2008;4:e35. doi:10.1371/journal.ppat.0040035. Published 15 February 2008.
4. Gulay Z, Imir T. Anti-candidial activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro, Immunobiology 1996; 195:220-230. (Pubitemid 26275769)
5. Baine WB, Koenig MG, Goodman JS. Clearance of Candida albicans from the bloodstream of rabbits. Infect Immun 1974; 10:1420-1425.
6. Louria DB, Fallon N, Browne HG. The influence of cortisone on experimental fungus infections in mice. J Clin Invest 1960; 39:1435-1449.
7. Meister H, Heymer B, Schafer H, Haferkamp O. Role of Candida albicans in granulomatous tissue reactions. II: In vivo degradation of C. albicans in hepatic macrophages of mice. J Infect Dis 1977; 135: 235-242.
8. Stone HH. Studies in the pathogenesis, diagnosis, and treatment of Candida sepsis in children. J Pediatr Surg 1974;9:127-133.
9. Taschdjian CL, Toni EF, Hsu KC, Seelig MS, Cuesta MB, Kozinn PJ. Immunofluorescence studies of Candida in human reticuloendothelial phagocytes: implications for immunogenesis and pathogenesis of systemic candidiasis. Am J Clin Pathol 1971;56:50-58.
10. Richard M, Ibata-Ombetta S, Dromer F, Bordon-Pallier F, Jouault T, Gaillardin C. Complete glycosylphosphatidylinositol anchors are required in Candida albicans for full morphogenesis, virulence, and resistance to macrophages. Mol Microbiol 2002;44:841-853.
11. Bailey DA, Feldmann PJ, Bovey M, Gow NA, Brown AJ. The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol 1996; 178:5353-5360.
12. Fu Y, Luo G, Spellberg BJ, Edwards JEJ, Ibrahim AS. Gene overexpression/suppression analysis of candidate virulence factors of Candida albicans. Eukaryot Cell 2008; 7:483-492. (Pubitemid 351959676)
13. Nusing R, Goerig M, Habenicht AJ, Ullrich V. Selective eicosanoid formation during HL-60 macrophage differentiation. Regulation of thromboxane synthase. Eur J Biochem 1993;212:371-376. (Pubitemid 23076103)
14. Spellberg BJ, Collins M, French SW, Edwards JE Jr, Fu Y, Ibrahim AS. A phagocytic cell line markedly improves survival of infected neutropenic mice. J Leukoc Biol 2005; 78:338-344. (Pubitemid 41061306)
15. Eiden-Plach A, Zagorc T, Heintel T, Carius Y, Breinig F, Schmitt MJ. Viral preprotoxin signal sequence allows efficient secretion of green fluorescent protein by Candida glabrata, Pichia pastoris, Saccharomyces cerevsiae, and Schizo- saccharomyces pombe. Appl Environ Microbiol 2004;70:961-966. (Pubitemid 38568221)
16. Avrova AO, Venter E, Birch PR, Whisson SC. Profiling and quantifying differential gene transcription in Phytophthora infestans prior to and during the early stages of potato infection. Fungal Genet Biol 2003; 40:4-14.
17. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003;2:1053-1060.
18. Spellberg B, Ibrahim AS, Yeaman MR, et al. The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun 2008; 76: 4574-4580.
19. Ibrahim AS, Spellberg BJ, Avenissian V, Fu Y, Filler SG, Edwards JE Jr. Vaccination with rAls1p-N improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun 2005; 73:999-1005. (Pubitemid 40165760)
20. Fu Y, Ibrahim AS, Sheppard DC, et al. Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol Microbiol 2002;44:61-72.
21. Nobile CJ, Andes DR, Nett JE, et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2006; 2:e63. doi:10.1371/journal.ppat.0020063. Published 7 July 2006.
22. Fradin C, De Groot P, MacCallum D, et al. Granulocytes govern the transcriptional response, morphology and proliferation of Candida abicans in human blood. Mol Microbiol 2005;56:397-415.
23. Castano I, Pan SJ, Zupancic M, Hennequin C, Dujon B, Cormack BP. Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol Microbiol 2005;55:1246-1258. (Pubitemid 40299191)
24. Schofield DA, Westwater C, Warner T, Nicholas PJ, Paulling EE, Balish E. Hydrolytic gene expression during oroesophageal and gastric candidiasis in immunocompetent and immunodeficient gnotobiotic mice. J Infect Dis 2003; 188:591-599. (Pubitemid 37011814)
25. Kumamoto CA, Vinces MD. Contributions of hyphae and hypha-coregulated genes to Candida albicans virulence. Cell Microbiol 2005; 7: 1546-1554.
26. Frohner IE, Bourgeois C, Yatsyk K, Majer O, Kuchler K. Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Mol Microbiol 2009;71:240-252.
27. Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995;63:1993-1998